Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Neoleukin Therapeutics Q2 Earnings

  Neoleukin Therapeutics (NASDAQ:NLTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Neoleukin Therapeutics (NASDAQ:NLTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Neoleukin Therapeutics beat estimated earnings by 6.67%, reporting an EPS of $-0.28 versus an estimate of $-0.3.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 0.88% increase in the share price the next day.

 

To track all earnings releases for Neoleukin Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For ManpowerGroup

By Benzinga Insights
July 18, 10:17 AM
ManpowerGroup (NYSE:MAN) is set to give its latest quarterly earnings report on Tuesday, 2022-07-19. Here's what investors need to know before the announcement. Analysts estimate that ManpowerGroup will report an earnings per share (EPS) of $2.34.

MAN